How Microbial Testing Keeps Vaccines Safe Vaccine and drug safety never stops. Manufacturers must have a contamination control strategy and no matter how long a

Endosafe Nexus Virtual Demonstration What if you could greatly reduce your current retest rate? The Endosafe® Nexus™ automated endotoxin testing system eliminates the complications and

Webinar: STAT Results for STAT Samples: Implementing Modern Rapid Micro Methods Webinar Overview Long incubation periods and subjective visual assessments have long hampered the efficiency

Rapid ATP-Bioluminescence for Non-sterile Product Testing: Roadmap to Implementation Webinar Overview Despite the clear advantages rapid microbiological methods (RMMs) provide over traditional ones, the pharmaceutical

Scientific Poster: Demonstrating Equivalency and Limit of Detection for a Rapid Sterility Method using ATP-Bioluminescence

Technical Report: Determining Proof of Concept of an Alternative Sterility Test Using Celsis AMPiScreen® Amplified ATP Bioluminescence on a Broad Range of Pharmaceutical Products Determining

What is Your Microbial ID Program Really Costing You? Take this five-question survey to start your cost analysis. START 

Optimizing MALDI-TOF for Filamentous Fungi Identification Webinar Overview Recovering fungal samples from environmental monitoring (EM) is a concern for all pharmaceutical, medical device, and consumer

Filamentous Fungi – Facilities Facing Facts Real risks affecting real people. Ziva Abraham discusses the reality and importance of preventing mold contamination Ziva Abraham is

Safety Doesn’t Stop After Approval How microbial testing keeps vaccines safe Vaccine development typically takes years, even decades. How then could companies deliver COVID-19 vaccines